StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 5/30
$2.44−0.16 (-6.15%)

Close on Nov 20, 2026Market cap $84.82MP/E –Yield –

Anixa Biosciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2012 it was $936.14K, down 3.4% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2012Oct 31, 2012$936.14K-3.4%
FY2011Oct 31, 2011$969.11K+49.5%
FY2010Oct 31, 2010$648.37K–

More Anixa Biosciences figures

See a number that looks wrong?